Stryker (NYSE:SYK – Free Report) had its target price increased by UBS Group from $339.00 to $351.00 in a report released on Wednesday, Benzinga reports. UBS Group currently has a neutral rating on the medical technology company’s stock. SYK has been the subject of a number of other research reports. TD Cowen lifted their price […]